Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis

To date, anti-tumor necrosis factor alfa (anti-TNF-α) therapy is the only alternative to nonsteroidal anti-inflammatory drugs for the treatment of ankylosing spondylitis. Etanercept is a soluble TNF receptor, with a mode of action and pharmacokinetics different to those of antibodies and distinctive...

Descripción completa

Detalles Bibliográficos
Autores principales: Senabre-Gallego, José Miguel, Santos-Ramírez, Carlos, Santos-Soler, Gregorio, Salas-Heredia, Esteban, Sánchez-Barrioluengo, Mabel, Barber, Xavier, Rosas, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790868/
https://www.ncbi.nlm.nih.gov/pubmed/24101863
http://dx.doi.org/10.2147/PPA.S33109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790868/
https://www.ncbi.nlm.nih.gov/pubmed/24101863
http://dx.doi.org/10.2147/PPA.S33109

Ejemplares similares